Search details
1.
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.
CA Cancer J Clin
; 2024 Jan 04.
Article
in English
| MEDLINE | ID: mdl-38174605
2.
Machine learning-based radiomics analysis in predicting RAS mutational status using magnetic resonance imaging.
Radiol Med
; 129(3): 420-428, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38308061
3.
Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems.
Semin Cancer Biol
; 84: 293-301, 2022 09.
Article
in English
| MEDLINE | ID: mdl-34389490
4.
Implementation of precision medicine in healthcare-A European perspective.
J Intern Med
; 294(4): 437-454, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37455247
5.
A multiple network-based bioinformatics pipeline for the study of molecular mechanisms in oncological diseases for personalized medicine.
Brief Bioinform
; 22(6)2021 11 05.
Article
in English
| MEDLINE | ID: mdl-34050359
6.
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
BMC Cancer
; 23(1): 1010, 2023 Oct 19.
Article
in English
| MEDLINE | ID: mdl-37858132
7.
Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications.
Mol Biol Rep
; 50(8): 7113-7120, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37340184
8.
European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
Int J Mol Sci
; 24(18)2023 Sep 07.
Article
in English
| MEDLINE | ID: mdl-37762091
9.
Point-of-Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip.
Angew Chem Int Ed Engl
; 62(51): e202309135, 2023 Dec 18.
Article
in English
| MEDLINE | ID: mdl-37672490
10.
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion.
Oncologist
; 27(1): 7-12, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-35305107
11.
Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.
BMC Cancer
; 22(1): 759, 2022 Jul 12.
Article
in English
| MEDLINE | ID: mdl-35820813
12.
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Int J Gynecol Cancer
; 32(6): 799-803, 2022 06 06.
Article
in English
| MEDLINE | ID: mdl-35318277
13.
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives.
Int J Mol Sci
; 23(2)2022 Jan 13.
Article
in English
| MEDLINE | ID: mdl-35055006
14.
The International Collaboration for Cancer Classification and Research.
Int J Cancer
; 148(3): 560-571, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-32818326
15.
SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system.
J Transl Med
; 19(1): 246, 2021 06 05.
Article
in English
| MEDLINE | ID: mdl-34090468
16.
Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Future Oncol
; 17(26): 3529-3539, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34254524
17.
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
BMC Cancer
; 20(1): 822, 2020 Aug 31.
Article
in English
| MEDLINE | ID: mdl-32867715
18.
FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.
Int J Mol Sci
; 21(18)2020 Sep 18.
Article
in English
| MEDLINE | ID: mdl-32962091
19.
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
BMC Cancer
; 19(1): 899, 2019 Sep 09.
Article
in English
| MEDLINE | ID: mdl-31500586
20.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Gynecol Oncol
; 153(3): 535-540, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30979589